Collegium Pharmaceutical, Inc. (COLL)

NASDAQ: COLL · IEX Real-Time Price · USD

32.36

+0.27 (0.84%)

At close: Jul 19, 2024, 4:00 PM

32.32

-0.04 (-0.12%)

Pre-market: Jul 20, 2024, 9:29 AM EDT

Collegium Pharmaceutical Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	2018 - 2013
Revenue	566.92	566.77	463.93	276.87	310.02	296.7	Upgrade
Revenue Growth (YoY)	8.00%	22.17%	67.56%	-10.69%	4.49%	5.81%	Upgrade
Cost of Revenue	226.7	240.6	254.45	126.25	130.18	193.66	Upgrade
Gross Profit	340.22	326.17	209.49	150.62	179.84	103.04	Upgrade
Selling, General & Admin	148.42	159.21	172.19	118.96	113.83	116.45	Upgrade
Research & Development	0	0	3.98	9.45	9.77	10.34	Upgrade
Other Operating Expenses	0	0	0	4.58	0	0	Upgrade
Operating Expenses	148.42	159.21	176.17	132.99	123.6	126.79	Upgrade
Operating Income	191.81	166.96	33.32	17.63	56.23	-23.75	Upgrade
Interest Expense / Income	79.25	83.34	63.21	21.01	28.88	0.91	Upgrade
Other Expense / Income	-17.36	7.89	-1.05	-0.01	-0.23	-1.94	Upgrade
Pretax Income	129.91	75.73	-28.85	-3.37	27.58	-22.72	Upgrade
Income Tax	36.62	27.58	-3.85	-74.89	0.83	0	Upgrade
Net Income	93.29	48.16	-25	71.52	26.75	-22.72	Upgrade
Net Income Growth	-	-	-	167.33%	-	-	Upgrade
Shares Outstanding (Basic)	32	34	34	35	34	33	Upgrade
Shares Outstanding (Diluted)	41	42	34	41	35	33	Upgrade
Shares Change	20.74%	23.53%	-17.58%	16.77%	5.07%	1.52%	Upgrade
EPS (Basic)	2.81	1.43	-0.74	2.05	0.78	-0.68	Upgrade
EPS (Diluted)	2.41	1.29	-0.74	1.86	0.76	-0.68	Upgrade
EPS Growth	-	-	-	144.74%	-	-	Upgrade
Free Cash Flow	308.16	274.29	122.61	101.61	-279.83	21.35	Upgrade
Free Cash Flow Per Share	9.53	8.13	3.62	2.91	-8.13	0.64	Upgrade
Gross Margin	60.01%	57.55%	45.15%	54.40%	58.01%	34.73%	Upgrade
Operating Margin	33.83%	29.46%	7.18%	6.37%	18.14%	-8.00%	Upgrade
Profit Margin	16.46%	8.50%	-5.39%	25.83%	8.63%	-7.66%	Upgrade
Free Cash Flow Margin	54.36%	48.40%	26.43%	36.70%	-90.26%	7.19%	Upgrade
Effective Tax Rate	28.19%	36.41%	-	-	3.01%	-	Upgrade
EBITDA	358.62	308.33	173.31	86.56	118.07	-20.77	Upgrade
EBITDA Margin	63.26%	54.40%	37.36%	31.26%	38.09%	-7.00%	Upgrade
Depreciation & Amortization	149.46	149.26	138.94	68.92	61.61	1.04	Upgrade
EBIT	209.16	159.07	34.37	17.64	56.46	-21.81	Upgrade
EBIT Margin	36.89%	28.07%	7.41%	6.37%	18.21%	-7.35%	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).